Legal Opinion
Cato Capital LLC v. Hemispherx Biopharma, Inc.
District Court, D. Delaware
Decided September 29, 2014No. Civil Action No. 09-549(GMS)PublishedCited by 2 opinions
1Opinion of the Court
MEMORAND UM
GREGORY M. SLEET, UNITED STATES DISTRICT JUDGE
I. INTRODUCTION
The plaintiff, Cato Capital LLC (“Cato Capital”), brought this action for damages and attorneys’ fees against Hemispherx Biopharma, Inc. (“Hemispherx”) alleging breach of contract, and fraudulent inducement, and against The Sage Group, Inc. (“Sage”) alleging fraud and intentional interference with contractual relationship.1 (D.I. 46.) Cato Capital claims entitlement to damages and attorneys’ fees.
The court held a three-day bench trial in this matter from March 4, 2013 through March 6, 2013. After the trial, each party…
2Cases cited21 opinions
- Rhone-Poulenc Basic Chemicals Co. v. American Motorists Insurance Co.Supreme Court of Delaware · 1992
- Lorillard Tobacco Co. v. American Legacy FoundationSupreme Court of Delaware · 2006
- Eagle Industries, Inc. v. DeVilbiss Health Care, Inc.Supreme Court of Delaware · 1997
- Deerfield Communications Corp. v. Chesebrough-Ponds, Inc.New York Court of Appeals · 1986
- Aeroglobal Capital Management, LLC v. Cirrus Industries, Inc.Supreme Court of Delaware · 2005
16 more not listed; retrieve them via the Exa API.
3Cited by2 opinions
- Cato Capital LLC v. Hemispherx Biopharma Inc.Court of Appeals for the Third Circuit · 2015
- Larian v. Momentus Inc.Superior Court of Delaware · 2024